Shabahang Shahrokh 4
4 · ADiTx Therapeutics, Inc. · Filed Nov 4, 2020
Insider Transaction Report
Form 4
Shabahang Shahrokh
DirectorCHIEF INNOVATION OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2020-11-02+110,000→ 110,000 totalExercise: $1.92Exp: 2030-11-02→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]The options shall vest as to 50% of the total shares on November 2, 2021, after which the remaining 50% of the total shares shall vest in four successive equal quarterly installments.